Review
Abstract
Zoonotic diseases such as brucellosis have a major impact on the health and economic prosperity of the developing world. Recent advances in our understanding of brucellosis and new developments in diagnostics and vaccine technology provide unique opportunities for biotechnology companies in developing countries to make an essential contribution to the control of this disease.
Key words: Brucellosis, biotechnology, zoonosis, livestock, public health, diagnostics, vaccine.
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0